Skip to Content

Label Changes for:

Veramyst (fluticasone furoate) Nasal Spray

May 2015

Changes have been made to the PRECAUTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)  

May 2015

USE IN SPECIFIC POPULATIONS

Hepatic Impairment
  • Use VERAMYST Nasal Spray with caution in patients with moderate or severe hepatic impairment [see Clinical Pharmacology (12.3)].

 

October 2011

WARNINGS AND PRECAUTIONS

Local Nasal Effects
  • section added

 

ADVERSE REACTIONS

Postmarketing Experience

Respiratory, Thoracic, and Mediastinal Disorders

  • add .... : Rhinalgia, nasal discomfort (including nasal burning, nasal irritation, and nasal soreness), nasal dryness, and nasal septal perforation

 

PATIENT COUNSELING INFORMATION

Keep Spray Out of Eyes
  • section added
Potential Drug Interactions
  • section added

 

Hide